跳至主要内容
临床试验/CTRI/2021/06/034474
CTRI/2021/06/034474尚未招募未知

Prevalence, predisposing factors and management of Head and Neck Lymphedema inpatients following treatment for Head and Neck Cancer. (HeNLy-1 Study)

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. All patients who have completed definitive HNC treatment
  • 2. Age > 18 years
  • 3. No current evidence of cancer.
  • 4. Time since the last cancer treatment should be at least 6 months
  • 5. At least some part of the definitive treatment must have been taken at Tata Memorial Hospital

排除标准

  • 1. Having metastatic cancer or any other active cancer, or
  • 2. Unable to understand the informed consent.

研究者

相似试验